BioPort A/S

 

ELECTRONIC VERSIONS OF MATERIALS REGARDING THE RIGHTS ISSUE OF A/S (“BIOPORTO” OR THE “COMPANY”) ARE BEING MADE AVAILABLE ON THIS WEBSITE IN GOOD FAITH BY THE COMPANY AND ARE FOR INFORMATION PURPOSES ONLY. BY ACCESSING THE DOCUMENT YOU ACKNOWLEDGE AND CONFIRM THE FOLLOWING.

Access to the information and documents contained on this website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons who wish to have access to information regarding the rights issue announced by the Company in company announcement 6 of 16 March 2020 (the “Announcement”), should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company assumes no responsibility if there is a violation of applicable laws and regulations by any person.

Persons resident or physically present in the United States, please note the following: This rights offering described in the Announcement is made for the securities of a foreign company. The offer is subject to the disclosure requirements of a foreign country that are different from those of the United States. Financial statements included in the document, if any, have been prepared in accordance with foreign accounting standards that may not be comparable to the financial statements of United States companies. It may be difficult for you to enforce your rights and any claim you may have arising under the federal securities laws, since the issuer is located in a foreign country, and some or all of its officers and directors may be residents of a foreign country. You may not be able to sue the foreign company or its officers or directors in a foreign court for violations of the U.S. securities laws. It may be difficult to compel a foreign company and its affiliates to subject themselves to a U.S. court's judgment.

The information in the Announcements is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction where to do so would constitute a violation of the local securities laws and regulation of such jurisdiction.

The Announcement does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy the New Shares (as defined below) or a part thereof in any jurisdiction to any person, to whom it is illegal to make such offer in the relevant jurisdiction.

If you are not permitted to view the Announcement or are in doubt as to whether you are permitted to view the Announcement, please exit this webpage.

By accessing the Announcement, you will be deemed to have accepted and understood the following:

  1. That you are not resident of any jurisdiction where accessing the Announcement is unlawful and you are not acting on behalf of someone who is resident of or located in any jurisdiction where accessing the Announcement is unlawful;
  2. You agree that you will not transmit or otherwise send any materials contained in the Announcement (either in whole or in part) to any person resident of or located in any jurisdiction where to do so would breach applicable law or regulation; and
  3. You have read and understood the disclaimer set out above. You understand that it may affect your rights and you agree to be bound by its terms. You confirm that you are permitted to proceed to the electronic version of the Announcement.

 

I do not accept.

 

 

BioPorto A/S  •  Tuborg Havnevej 15, st.  •  DK-2900 Hellerup  •  P: +45 45 29 00 00  •  F: +45 45 29 00 01  •  bioporto.com